Sigma Healthcare poaches Total Tools boss

Sigma Healthcare has poached an experienced executive to be its new chief financial officer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Sigma Healthcare has appointed a new chief financial officer. 
  • The new hire has decades of experience, including at a high level with JB Hi-Fi. 
  • The company's shares traded higher on the news.
A senior pharmacist talks to a customer at the counter in a shop.

Image source: Getty Images

Chemist Warehouse owner Sigma Healthcare Limited (ASX: SIG) has poached the boss of Total Tools to be its new chief financial officer.

The $34.6 billion company, created in February from the merger of the ASX-listed Sigma and the privately held Chemist Warehouse Group, said on Tuesday that Total Tools' Richard Murray would join on October 13.

Richard has extensive ASX listed company experience spanning over 30 years. Most recently, he was the Chief Executive Officer of Total Tools, a Division of Metcash Limited. Previously, Richard was with Premier Investments Ltd where he was CEO Premier Retail, overseeing The Just Group's seven retail brands with around 1100 stores globally.

Prior to his time at Premier, Mr Murray held senior leadership positions with JB Hi-Fi Limited (ASX: JBH) for almost 20 years, Sigma said, joining ahead of that company's listing on the ASX and overseeing its ascension to be an S&P/ASX 100 Index (ASX: XTO) company.

Most notably, Richard was Chief Financial Officer for twelve years and Chief Executive Officer for seven years. During this period, Richard drove strong store and revenue growth, focused on cost management and financial reporting, and the acquisition and subsequent integration of The Good Guys business.

Sigma shares traded as high as $3.05 on the news of Mr Murray's appointment before moderating to be changing hands for $3.02, up 2.4 cents.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor and an elderly couple sit at a desk and look at a lung scan uploaded.
Healthcare Shares

Why did 4DMedical shares charge higher today, then drop?

The company's key technology has received a big tick.

Read more »

Business woman working from home with stock market chart showing percent change on her laptop screen.
Healthcare Shares

Should I invest $10,000 in CSL shares before the end of May?

This ASX healthcare giant has fallen hard, but the lower price and improving dividend appeal make it worth another look.

Read more »

A woman wakes up after sleeping soundly, stretching her arms high sitting in bed.
Healthcare Shares

Why this fallen ASX 200 blue chip could be a strong buy

I think the market may be underestimating the durability of this healthcare business.

Read more »

Female pharmacist smiles with a digital tablet.
Broker Notes

3 reasons to buy Sigma Healthcare shares today

A leading analyst expects “impressive growth” from Sigma Healthcare shares.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news.
Healthcare Shares

Could this fallen ASX 200 stock be a once-in-a-decade opportunity?

The valuation now looks far more interesting for a healthcare stock with a global leadership position.

Read more »

Hand dropping a mic.
Healthcare Shares

Pro Medicus shares jump as massive US contract win turns heads

Pro Medicus shares are rocketing after a major US win.

Read more »

Two business people shaking hands in an office
Healthcare Shares

Pro Medicus inks $90m contract

Pro Medicus signs a major $90m contract with Beth Israel Lahey Health, boosting its North American growth outlook.

Read more »

Shattered investor with head in hands, with ASX chart in the background.
Healthcare Shares

CSL shares crash, but is a comeback looming?

Has the market become too pessimistic about Australia's biotech giant?

Read more »